TAS5315

TAS5315 · Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAS5315, covering 2020-08-17 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria [Phase 2]